IN8bio, Inc. (INAB)

NASDAQ

$1.08

$+0.02

(+2.26%)

Regular Market

IN8bio, Inc. (INAB) Live Price Chart

Last updated: ⁦2026-10-22 15:47:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

IN8bio, Inc. (INAB) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.08, with a market capitalization of $11.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.88 to $2.73. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$11.24M
Open	$1.06
Day's High	$309.57
Day's Low	$0.88
Previous Close	$1.09
Volume	20.44K
Average Volume	54.33K
P/E Ratio	--
52-Week High	$2.73
52-Week Low	$0.88
Dividend Yield	--
Earnings Date	--

IN8bio, Inc. (INAB) Stock Price Today

IN8bio, Inc. (INAB) is currently trading at $1.08 as of 2026-10-22 15:43:00, down 0.55% ($0.01) from the previous close of $1.09

During today's regular trading session, INAB has traded between $0.88 and $309.57, with a trading volume of 20.44K shares. The current price is near the lower end of today's range.

IN8bio, Inc. (INAB) 7-Day Stock Price Change

Over the past seven days, IN8bio, Inc. (INAB) moved from $1.18 to $1.08, representing a decline of 8.14% ($0.10).

The stock traded between $1.03 and $1.26 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 33.75 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

INAB 52-Week Price Position

Position in Range: 11.0%

52W Low$0.88

52W High$2.73

INAB is currently trading at $1.08, placing it 11.0% of the way from its 52-week low of $0.88 to its 52-week high of $2.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is IN8bio, Inc. (INAB)?

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

IN8bio, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	18
Exchange	NASDAQ
Company Website	https://www.in8bio.com

How to Buy IN8bio, Inc. (INAB) Stock on MEXC

Eligible investors can buy real shares of IN8bio, Inc. (INAB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INAB and Place Your Order

Open the RealStocks trading page and search for INAB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is IN8bio, Inc. (INAB) stock price today?

IN8bio, Inc. (INAB) is currently trading at $ 1.08, down 0.55% ($0.01) from the previous close of $ 1.09. Intraday prices update in real time during regular trading hours.

2.Is INAB stock going up or down today?

As of 2026-10-22 15:43:00, INAB is trading at $ 1.08, down 0.55% ($0.01) from its previous close of $ 1.09. The stock has traded between $ 0.88 and $ 309.57 during today’s regular session. Past price movements do not guarantee future results.

3.What is INAB pre-market price?

As of 2026-10-22 15:43:00, INAB is trading at $ 1.07 in pre-market trading, down 1.74% ($0.02) from the previous close of $ 1.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INAB after-hours price?

As of 2026-10-22 15:43:00, INAB is trading at $ 1.09 in after-hours trading, up 0.37% ($0.00) from the regular-session close of $ 1.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INAB stock trading now?

INAB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INAB sit relative to its 52-week high and low?

Over the past 52 weeks, INAB has traded between a low of $ 0.88 and a high of $ 2.73. At $ 1.08, the stock is positioned 11.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is IN8bio, Inc. in?

IN8bio, Inc. (INAB) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is IN8bio, Inc.'s market capitalization and where is it listed?

IN8bio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 11.24M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INAB valued in terms of P/E ratio and EPS?

INAB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does IN8bio, Inc. pay a dividend?

IN8bio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.